About this episode
Season 4 is here! Tune in for the first episode. Luis talks to Dr. Paul Hergenrother about lolamicin. Dr. Hergenrother is a Professor of Chemistry at the University of Illinois in Urnaba-Champaign. He was previously a guest in the podcast (fabimycin episode) and this time he returns to talk about another potential antibiotic candidate: lolamicin. What is lolamicin? What is the mechanism of action? What organisms does it have activity against? Does it affect the gut microbiota?
Link to Dr. Hergenrother's article: https://www.nature.com/articles/s41586-024-07502-0
Questions? Feedback? Send those to [email protected]
Want to support the podcast? Here's how:
Venmo: https://venmo.com/u/letstalkmicro
Buy me a Ko-fi: https://ko-fi.com/letstalkmicro
Get every episode summarized
Each time Let's Talk Micro publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Let's Talk Micro
242: Microbiology & Infection Prevention: Partners in Crime
Let's Talk Micro
241: What Can Whole Genome Sequencing Realistically Tell Us About Resistance?
Let's Talk Micro
240: CLSI M100 2026: Actualizaciones
Let's Talk Micro
239: Inside ASM Microbe 2026
Let's Talk Micro